September 2016

Features

Stem Cells for Retina: Where Are We Now?

A review of multiple trials pursuing a breakthrough in cell-based therapies for AMD and hereditary retinal disorders.

Diabetes Drugs In the Retina Practice

How glucose-lowering therapies can influence surgical planning.

Taking OCT Out To The Retinal Periphery

How ultra-widefield spectral domain optical coherence tomography gives us a new view of pathology.

Will OCT Angiography Replace FA?

A close look at how this emerging imaging modality compares with the gold standard.

Departments

Clinical Trial Closeup

Drugability of the Suprachoroidal Space

Phase II trial shows Clearside’s CLS-TA safe and effective in noninfectious uveitis.

Coding Commentary

Get Ready For ICD-10 Changes

The one-year reprieve ends October 1. Here’s what you can expect and how to prepare.

Editor's Page

Innovation Insight

25 Years On, OCT Looks To Future

Co-inventor David Huang, PhD, shares the next big thing for today’s big thing.

News

North of the Border

MIVS and Post-op Endophthalmitis

A look at evolving trends and techniques.

Retina CEO

Benchmarking Tool Can Track Coding

Retina PractiCare tool can show how your claims compare with peers’­—and maybe help keep auditors away.

Retina Fellows Forum

Next-Generation Therapies For Wet AMD: Upgrade 2.0

Making the case for combination therapies.

Retina Rounds

Managing High-Risk Asymptomatic RRD

Navigating a management dilemma in this young surgeon who had LASIK.

Surgical Pearl Video

A Novel Approach for Surgical PVD

This hydrodissection approach avoids risks of iatrogenic retinal tears and optic nerve traction.

Video Vault

Minimally invasive management of lenticular deposits

Akshay Thomas, MD, MS, of Tennessee Retina demonstrates his surgical technique for removing posterior intraocular lens deposits.